REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 88 filers reported holding REVANCE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88,319 | -98.4% | 7,700 | -95.4% | 0.00% | -100.0% |
| Q1 2023 | $5,397,365 | -66.3% | 167,568 | -71.3% | 0.01% | -71.0% |
| Q2 2018 | $16,001,000 | -10.9% | 582,900 | 0.0% | 0.03% | +3.3% |
| Q1 2018 | $17,953,000 | -13.8% | 582,900 | 0.0% | 0.03% | -23.1% |
| Q4 2017 | $20,839,000 | +29.8% | 582,900 | 0.0% | 0.04% | +18.2% |
| Q3 2017 | $16,059,000 | +4.4% | 582,900 | 0.0% | 0.03% | -5.7% |
| Q2 2017 | $15,389,000 | +26.9% | 582,900 | 0.0% | 0.04% | +9.4% |
| Q1 2017 | $12,124,000 | +0.5% | 582,900 | 0.0% | 0.03% | -27.3% |
| Q4 2016 | $12,066,000 | +27.7% | 582,900 | 0.0% | 0.04% | +25.7% |
| Q3 2016 | $9,449,000 | +13.8% | 582,900 | -4.5% | 0.04% | +2.9% |
| Q2 2016 | $8,300,000 | -22.1% | 610,300 | 0.0% | 0.03% | -22.7% |
| Q1 2016 | $10,656,000 | -48.9% | 610,300 | 0.0% | 0.04% | -54.2% |
| Q4 2015 | $20,848,000 | +14.8% | 610,300 | 0.0% | 0.10% | +28.0% |
| Q3 2015 | $18,163,000 | – | 610,300 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |